跳至主要内容
临床试验/NCT03386201
NCT03386201Unknown不适用

FLuorescence Cholangiography Using Methylene Blue

University of Oxford1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Concordance of surgeon anatomy definition with fluorescence outline

研究概览

简要总结

Open label prospective, non-randomised proof of principle study assessing the use of methylene blue fluorescence cholangiography.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 years or above.
  • Undergoing laparoscopic cholecystectomy

排除标准

  • Patient who is unable or unwilling to give informed consent
  • Known allergy to methylene blue
  • Risk of serotonin syndrome (taking SSRI / G6PD deficiency / previous serotonin syndrome)
  • Significant renal failure
  • Pregnant / planning pregnancy or breastfeeding

研究组 & 干预措施

Intravenous methylene blue

Experimental

干预措施: Intravenous Methylene blue (Drug)

结局指标

主要结局

Concordance of surgeon anatomy definition with fluorescence outline

时间窗: Intraoperative (At end of laparoscopic cholecystectomy)

次要结局

  • Signal to background ratio over time throughout laparoscopic cholecystectomy(0, 10, 20, 30, 40, 50, 60, minutes and at 10 minute intervals thereafter post injection of methylene blue)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

DrThomasBarnes

Clinical Research Fellow

University of Oxford

研究点 (1)

Loading locations...

相似试验